Menlo Park, CA, United States of America

Bradley Kelemen

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Danisco (China) Holding Co., Ltd.. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Bradley Kelemen

Introduction

Bradley Kelemen is an accomplished inventor based in Menlo Park, California. He has made significant contributions to the field of biotechnology, particularly through his innovative work on esterase and its applications. With a focus on practical solutions, Kelemen has developed a patent that showcases his expertise and creativity.

Latest Patents

Kelemen holds a patent for "Esterase and Methods of Use, Thereof." This patent highlights his ability to create valuable inventions that can have a substantial impact on various industries. His work in this area demonstrates a commitment to advancing scientific knowledge and practical applications.

Career Highlights

Kelemen is currently employed at Danisco (China) Holding Co., Ltd., where he continues to push the boundaries of innovation. His role at the company allows him to collaborate with other talented professionals and contribute to groundbreaking projects. With a total of 1 patent, Kelemen's work is recognized within the industry.

Collaborations

Throughout his career, Kelemen has worked alongside notable colleagues, including Feng Guo and Helong Hao. These collaborations have enriched his work and fostered an environment of shared knowledge and innovation.

Conclusion

Bradley Kelemen is a notable inventor whose contributions to biotechnology are evident through his patent and collaborative efforts. His work continues to inspire advancements in the field, showcasing the importance of innovation in driving progress.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…